Marine bacteria and fungi as promising source for new antibiotics

Drug Dev Res. 2019 Feb;80(1):24-27. doi: 10.1002/ddr.21482. Epub 2018 Oct 28.

Abstract

Natural products and derivatives thereof are of considerable importance in the discovery of new pharmaceuticals, for example, for the treatment of cancer, diabetes, inflammation diseases, and infection diseases caused by bacteria, fungi, viruses, or parasites. The great biodiversity of marine microorganisms is reflected in their huge chemical diversity, which provides a rich source of biologically active compounds. An increasing interest in marine microorganisms as promising producers of new compounds with potential medical applications has raised increasing interest in the sustainable exploration of marine microbial resources for the discovery of new antibiotics, which is highlighted. The bottlenecks in the development of drugs using the large marine natural product pipeline are also discussed.

Keywords: antibiotics; biodiscovery; marine bacteria; marine fungi; marine natural products.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / isolation & purification
  • Anti-Bacterial Agents / pharmacology*
  • Antifungal Agents / isolation & purification
  • Antifungal Agents / pharmacology*
  • Aquatic Organisms* / isolation & purification
  • Aquatic Organisms* / microbiology
  • Bacteria / isolation & purification
  • Biological Products / isolation & purification
  • Biological Products / pharmacology*
  • Drug Resistance, Bacterial / drug effects
  • Drug Resistance, Bacterial / physiology
  • Drug Resistance, Fungal / drug effects
  • Drug Resistance, Fungal / physiology
  • Fungi / isolation & purification
  • Humans

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Biological Products